NPI registry status
Active
2026 NPPES data Transplant Surgery Physician NPI 1730497454 MD
Verify on CMS → GENE IM, MD
Transplant Surgery Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
Federal data — no proprietary rating.
PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 118 beneficiaries · Transplant Surgery Physician avg: 275
Generic prescribing
88%
generic claims · 12% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$14.5K
8 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: GENE IM, MD is a Transplant Surgery Physician ([object Object]) practicing in NEW YORK, New York with a Medicare Part D prescribing footprint of 1K claims across 118 beneficiaries — 12% brand-name prescribing . Industry payments of $14.5K across 8 transactions are disclosed under CMS Open Payments (Sunshine Act).
What stands out: GENE IM, MD filed 1,356 Medicare Part D claims in 2023 across NEW YORK, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
✓
Board certification likely (heuristic — not verified)
GENE IM, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
GENE IM, MD at a glance
Quality data not reportedPrimary specialty
Transplant Surgery Physician
Medicare Part D claims
1,356 393% vs specialty avg
Specialty distribution in New York
How Transplant Surgery Physician compares to other specialties among New York providers
Transplant Surgery Physician share within New York
Specialty board-certification context
Estimated specialty board-certified rate — Transplant Surgery Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Transplant Surgery Physician ABMS/AOA estimate
Est. board-certified rate (Transplant Surgery Physician) — ABMS / AOA estimate
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
GENE IM, MD is a Transplant Surgery Physician provider practicing in NEW YORK, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1730497454. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
GENE IM, MD appears in the CMS NPPES registry as a Transplant Surgery Physician provider holding MD credentials at 622 W 168TH ST FL 14, NEW YORK, NY, 10032, with a listed phone of (212) 305-0914. NPI 1730497454 was issued on 09/15/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what IM most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,356 prescription claims written by this provider, covering 118 Medicare beneficiaries and totaling roughly $581K in drug spend, split 12% brand-name and 88% generic by claim count, with an opioid prescribing rate of 4.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Transplant Surgery Physician is a narrow specialty nationwide, with 1,026 enrolled providers across 48 states and an average of 275 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1730497454 |
|---|---|
| Specialty | Transplant Surgery Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 09/15/2010 |
Hospital and facility affiliations
Facilities where GENE IM, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
NEW YORK, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for GENE IM, MD. Source: openpaymentsdata.cms.gov.
Total received
$14.5K
Largest payer
Novo Nordisk Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — New York NYSBPMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to GENE IM, MD. To verify GENE IM, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
GENE IM, MD — brand share 12.0%
Specialty average (est.)
12% brand-name claims vs 88% generic, on 1,356 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,356
Total Claims
$581K
Total Drug Cost
118
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,048
- Total Day Supply
- 59,670
- Brand vs Generic
- 12% brand / 88% generic
- Brand Drug Cost
- $443K
- Generic Drug Cost
- $137K
- Opioid Claims
- 55 (4.1% rate)
- Antibiotic Claims
- 71
Patient Demographics
- Average Patient Age
- 66.8 years
- Avg HCC Risk Score
- 2.92
- Gender Split
- 47% female / 53% male
- Age Distribution
- <65: 30, 65-74: 69, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Tacrolimus | 118 |
| Furosemide | 97 |
| Pantoprazole Sodium | 75 |
| Spironolactone | 65 |
| Ursodiol | 56 |
| Amlodipine Besylate | 38 |
| Metoprolol Succinate | 38 |
| Lactulose | 37 |
| Prednisone | 37 |
| Xifaxan Rifaximin | 37 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Transplant Surgery Physician Overview
How GENE IM, MD fits within the Transplant Surgery Physician landscape nationally.
1,026
Transplant Surgery Physician Providers in US
48
States with Transplant Surgery Physician
275
Avg Claims per Provider
GENE IM, MD's 1,356 claims are above the specialty average of 275.
Nearby Transplant Surgery Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as IM.
Dr. SHALEEN AGARWAL
MD
ROCHESTER, NY
Dr. ABDULELAH ALHAWSAWI
M.D.
NEW YORK, NY
Dr. SCOTT AMES
MD
NEW YORK, NY
Dr. ANTONIOS ARVELAKIS
MD
NEW YORK, NY
Dr. KOFI ATIEMO
MD
NEW YORK, NY
Compare Transplant Surgery Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New York
Frequently Asked Questions
What is GENE IM, MD's specialty? ▼
GENE IM, MD specializes in Transplant Surgery Physician and practices in NEW YORK, New York. Credentials: MD.
How much does GENE IM, MD prescribe under Medicare Part D? ▼
In 2023, GENE IM, MD wrote 1,356 Medicare Part D claims totaling $581K in drug costs for 118 beneficiaries.
Where is GENE IM, MD located? ▼
GENE IM, MD is located at 622 W 168TH ST FL 14, NEW YORK, NY, 10032. Phone: (212) 305-0914.
What is GENE IM, MD's NPI number? ▼
GENE IM, MD's National Provider Identifier (NPI) is 1730497454, issued on 09/15/2010.
Does GENE IM, MD prescribe more brand-name or generic drugs? ▼
GENE IM, MD's prescribing is 12% brand-name and 88% generic drugs by claim count, with $443K in brand drug costs.
Does GENE IM, MD prescribe opioids? ▼
Yes, GENE IM, MD had 55 opioid claims in 2023 with an opioid prescribing rate of 4.1%.
How many Transplant Surgery Physician providers are there in the US? ▼
There are 1,026 Transplant Surgery Physician providers across 48 states in the US. The average Transplant Surgery Physician provider writes 275 Medicare Part D claims per year.
What drugs does GENE IM, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, GENE IM, MD's most frequently prescribed drugs include Tacrolimus, Furosemide, Pantoprazole Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does GENE IM, MD accept Medicare? ▼
GENE IM, MD appears in CMS Medicare data with 1,356 Part D claims and 118 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify GENE IM, MD's credentials? ▼
GENE IM, MD's NPI is 1730497454 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology